#NephMadness 2025: Meet the Gamemakers
We are a few weeks out from the launch of the 13th NephMadness! This year’s Executive Team features plenty of familiar faces, as well as a few new ones. These are the folks that have been wo…
Related Articles
American Society of Nephrology | Member Services – Home
Take advantage of the benefits of ASN membership. Join ASN or renew membership online.
Finerenone: Completing the Cardiorenal Guideline-Directed Medical Therapy?
“Finerenone: Completing the Cardiorenal Guideline-Directed Medical Therapy?” published on 08 Jan 2025 by American Society of Nephrology.
Optimal Starts in Value-Based Care | RPA
COURSE DESCRIPTION This webinar will explore how to increase optimal starts in kidney patients, including tools and resources…
Effect of Sparsentan Versus Irbesartan With Genetic FSGS | Docwire News
Researchers evaluated the efficacy of sparsentan in a subset of patients with genetic focal segmental glomerulosclerosis.
#NephMadness 2025: Meet the Gamemakers
We are a few weeks out from the launch of the 13th NephMadness! This year’s Executive Team features plenty of familiar faces, as well as…
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
The blood–brain barrier is a physiological barrier that can prevent both small and complex drugs from reaching the brain to exert a pharmacological effect. For…
